Cross Country Healthcare, Inc.
$9.96
▼
-1.5%
2026-04-21 05:56:01
www.crosscountry.com
NMS: CCRN
Explore Cross Country Healthcare, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$317.69 M
Current Price
$9.96
52W High / Low
$14.99 / $7.43
Stock P/E
—
Book Value
$10.18
Dividend Yield
—
ROCE
-1.05%
ROE
-25.57%
Face Value
—
EPS
$-2.93
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
7,890
Beta
0.34
Debt / Equity
0.72
Current Ratio
3.78
Quick Ratio
3.78
Forward P/E
33.86
Price / Sales
0.29
Enterprise Value
$199.96 M
EV / EBITDA
10.79
EV / Revenue
0.19
Rating
None
Target Price
$11.67
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | The Oncology Institute, Inc. | $3.52 | — | $349.89 M | — | -38.51% | 999.19% | $4.88 / $1.8 | $-0.16 |
| 2. | Enhabit, Inc. | $13.72 | — | $702.56 M | — | 6.13% | -0.46% | $14.22 / $6.47 | $10.53 |
| 3. | Aveanna Healthcare Holdings Inc. | $6.87 | 6.54 | $1.47 B | — | 16.39% | 6.16% | $10.32 / $3.73 | $0.93 |
| 4. | PACS Group, Inc. | $36 | 28.88 | $5.53 B | — | 6.76% | 22.96% | $43.08 / $7.5 | $6.04 |
| 5. | Healthcare Services Group, Inc. | $19.32 | 22.48 | $1.33 B | — | 8.94% | 11.69% | $22.98 / $9.12 | $7.33 |
| 6. | Tenet Healthcare Corporation | $189.93 | 12.26 | $16.56 B | — | 13.64% | 27.02% | $247.21 / $109.82 | $48.53 |
| 7. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 236.76 M | 250.05 M | 274.07 M | 293.41 M | 309.94 M |
| Operating Profit | -7.1 M | -0.06 M | 1.85 M | 1.4 M | 2.08 M |
| Net Profit | -82.93 M | -4.77 M | -6.66 M | -0.49 M | -3.75 M |
| EPS in Rs | -2.58 | -0.15 | -0.21 | -0.02 | -0.12 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.05 B | 1.34 B | 2.02 B | 2.8 B |
| Operating Profit | -3.9 M | 22.68 M | 131.73 M | 287.67 M |
| Net Profit | -94.85 M | -14.56 M | 72.63 M | 185.98 M |
| EPS in Rs | -2.95 | -0.45 | 2.26 | 5.78 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 448.95 M | 589.25 M | 681.06 M | 947.84 M |
| Total Liabilities | 126.13 M | 170.29 M | 213.41 M | 490.62 M |
| Equity | 322.82 M | 418.96 M | 467.65 M | 457.22 M |
| Current Assets | 293.59 M | 335 M | 416.88 M | 675.67 M |
| Current Liabilities | 77.76 M | 120.4 M | 156.08 M | 271.64 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 48.25 M | 120.12 M | 248.5 M | 134.05 M |
| Investing CF | -8.16 M | -8.71 M | -13.78 M | -43.87 M |
| Financing CF | -13.01 M | -46.85 M | -221.24 M | -87.6 M |
| Free CF | 40.09 M | 111.4 M | 234.52 M | 125.26 M |
| Capex | -8.16 M | -8.71 M | -13.97 M | -8.79 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -33.46% | -27.95% | — | — |
| Earnings Growth % | -120.04% | -60.95% | — | — |
| Profit Margin % | -1.08% | 3.6% | 6.63% | — |
| Operating Margin % | 1.69% | 6.52% | 10.26% | — |
| Gross Margin % | 20.41% | 22.3% | 22.28% | — |
| EBITDA Margin % | 0.3% | 6.4% | 9.99% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.